Clinical mitochondrial genetics

Journal of Medical Genetics

Volumn 36, Issue 6, 1999, Pages 425-436

  Chinnery, Patrick F ^a   Howell, Neil ^b   Andrews, Richard M ^a   Turnbull, Douglass M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Genetic counselling; Heteroplasmy; Mitochondrial disease; Mitochondrial DNA

Indexed keywords

DOUBLE STRANDED DNA; MITOCHONDRIAL DNA; NUCLEIC ACID; UBIDECARENONE; VITAMIN;

AEROBIC METABOLISM; AUTOSOMAL RECESSIVE INHERITANCE; BASE PAIRING; BLOOD CHEMISTRY; CARDIOVASCULAR SYSTEM; CELL NUCLEUS; CLINICAL FEATURE; CLINICAL GENETICS; DERMATOLOGY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DETERMINATION; ENDOCRINE SYSTEM; FRIEDREICH ATAXIA; GASTROINTESTINAL TRACT; GENE MUTATION; GENE REARRANGEMENT; GENE THERAPY; GENETIC COUNSELING; GENOME; HEMATOLOGY; HEREDITARY MOTOR SENSORY NEUROPATHY; HISTOCHEMISTRY; HUMAN; METABOLIC DISORDER; MUSCLE BIOPSY; NEUROMUSCULAR SYSTEM; POINT MUTATION; PRIORITY JOURNAL; PSYCHIATRY; RENAL SYSTEM PARAMETERS; RESPIRATORY CHAIN; REVIEW; WILSON DISEASE;

DNA, MITOCHONDRIAL; FEMALE; GENETICS, MEDICAL; HUMANS; MALE; MITOCHONDRIA; MITOCHONDRIAL MYOPATHIES; MUTATION; PREGNANCY; PRENATAL DIAGNOSIS;

ATAXIA;

EID: 0033031577     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (196)

1. Koutnikova H, Campuzano V, Foury F, Dolle P, Cazzalini O, Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet 1997;16:345-51.
2. Rotig A, de Lonlay P, Chretien D, et al. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia. Nat Genet 1997;17:215-17.
3. Lutsenko S, Cooper MJ. Localization of the Wilson's disease protein product to mitochondria. Proc Natl Acad Sci USA 1998;95:6004-9.
4. Casari G, De Fusco M, Ciarmatori S, et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1908;93:973-83.
5. Holt I, Harding AE, Morgan-Hughes JA. Deletion of muscle mitochondrial DNA in patients with mitochondrial myopathies. Natue 1988;331:717-19.
6. Moraes CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med 1989;320:1293-9.
7. Zeviani M, Moraes CT, DiMauro S, et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988;38:1339-46.
8. Cormier V, Rotig A, Rasore Q, et al. Widespread multitissue deletions of the mitochondrial genome in Pearsons marrow-pancreas syndrome. J Pediatr 1989;117:599-602.
9. Ballinger SW, Shoffner JM, Hedaya EV, et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1992;1:11-15.
10. Chalmers RM, Brockington M, Howard RS, Lecky BR, Morgan-Hughes JA, Harding AE. Mitochondrial encephalopathy with multiple mitochondrial DNA deletions. J Neurol Sci 1996;143:41-5.
11. Ohno K, Tanaka M, Sahashi K. Mitochondrial DNA deletions in inherited recurrent myoglobinuria. Ann Neurol 1991;29:364-9.
12. Fadic R, Russell JA, Vedanarayanan VV, Lehar M, Kuncl RW, Johns DR. Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease. Neurology 1997;49:239-45.
13. Wallace DC, Singh G, Lott MT, et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988;242:1427-30.
14. Howell N, Kubacka I, Xu M, McCullough DA. Leber hereditary optic neuropathy:involvement of the mitochondrial ND1 gene and evidence for an intragenic suppressor mutation. Am J Hum Genet 1991;48:935-42.
15. Johns DR, Neufeld MJ, Park RD. An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun 1992;187:1551-7.
16. De Vries DD, Went LN, Bruyn GW, et al. Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia. Am J Hum Genet 1996;58:703-11.
17. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 1994;91:6206-10.
18. Manfredi G, Schon EA, Moraes CT, et al. A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene. Neuromusc Disord 1995;5:391-8.
19. Santorelli FM, Tanji K, Kulikova R, et al. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem Biophys Res Commun 1997;238:326-8.
20. Hanna MG, Nelson IP, Rahman S, et al. Cytochrome c oxidase deficiency associated with the first stop-codon point mutation in human mtDNA. Am J Hum Genet 1998;63:29-36.
21. Campos Y, Martin MA, Rubio JC, Gutierrez del Olmo MC, Cabello A, Arenas J. Bilateral striatal necrosis and MELAS associated with a new T3308C mutation in the mitochondrial ND1 gene. Biochem Biophys Res Commun 1997;238:323-5.
22. De Meirleir L, Seneca S, Lissens W, Schoentjes E, Desprechins B. Bilateral striatal necrosis with a novel point mutation in the mitochondrial ATPase 6 gene. Pediatr Neurol 1995;13:242-6.
23. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428-33.
24. de Vries DD, van Engelen BGM, Gabreels FJM, Ruitenbeek W, van Oost BA. A second missense mutation in the mitochondrial ATPase 6 gene mutation in Leigh's syndrome. Ann Neurol 1993;34:410-12.
25. Campos Y, Martin MA, Rubio JC, et al. Leigh syndrome associated with the T9176C mutation in the ATPase 6 gene of mitochondrial DNA. Neurology 1997;49:595-7.
26. Thyagarajan D, Shanske S, Vazquez-Memije M, De Vivo D, DiMauro S. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol 1995;38:468-72.
27. Taylor RW, Chinnery PF, Haldane F, et al. MELAS associated with a mutation in the valine transfer RNA gene of mitochondrial DNA. Ann Neurol 1996;40:459-62.
28. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-3.
29. Morten KJ, Cooper JM, Brown GK, Lake BD, Pike D, Poulton J. A new point mutation associated with mitochondrial encephalomyopathy Hum Mol Genet 1993;2:2081-7.
30. Nishino I, Komatsu M, Kodama S, Horai S, Nonaka I, Goto Y. The 3260 mutation in mitochondrial DNA can cause mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Muscle Nerve 1996;19:1603-4.
31. Goto YI, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). Biochem Biophys Acta 1991;1097:238-40.
32. Goto Y, Tsugane K, Tanabe Y, Nonaka I, Horai S. A new point mutation at nucleotide pair 3291 of the mitochondrial tRNA(Leu(UUR)) gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Biochem Biophys Res Commun 1994;202:1624-30.
33. Manfredi G, Schon EA, Bonilla E, Moraes CT, Shanske S, DiMauro S. Identification of a mutation in the mitochondrial tRNA(Cys) gene associated with mitochondrial encephalopathy. Hum Mutat 1996;7:158-63.
34. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 1990,61:931-7.
35. Silvestri G, Moraes CT, Shanske S, Oh SJ, DiMauro S. A new mtDNA mutation in the tRNA(Lys) gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am J Hum Genet 1992;51:1213-7.
36. Ozawa M, Nishino I, Horai S, Nonaka I, Goto YI. Myoclonus epilepsy associated with ragged-red fibers:a G-to-A mutation at nucleotide pair 8363 in mitochondrial tRNA(Lys) in two families. Muscle Nerve 1997;20:271-8.
37. Nakamura M, Nakano S, Goto Y, et al. A novel point mutation in the mitochondrial tRNA(Ser(UCN)) gene detected in a family with MERRF/MELAS overlap syndrome. Biochem Biophys Res Commun 1995;214:86-93.
38. Zeviani M, Muntoni F, Savarese N, et al. A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene (published erratum appears in Eur J Hum Genet 1993;1:124). Eur J Hum Genet 1993;1:80-7.
39. Reardon W, Ross RJ, Sweeney MG, et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992;340:1376-9.
40. Lynn S, Wardell T, Johnson MA, et al. Mitochondrial diabetes:investigation and identification of a novel mutation. Diabetes 1998;47:1800-2.
41. Silvestri G, Bertini E, Servidei S, et al. Maternally inherited cardiomyopathy:a new phenotype associated with the A to G AT nt.3243 of mitochondrial DNA (MELAS mutation). Muscle Nerve 1997;20:221-5.
42. Kawarai T, Kawakami H, Kozuka K, et al. A new mitochondrial DNA mutation associated with mitochondrial myopathy:tRNA(Leu)(UUR) 3254C-to-G. Neurology 1997;49:598-600.
43. Leu(UUR). Lancet 1991;338:143-7.
44. Silvestri G, Santorelli FM, Shanske S, et al. A new mtDNA mutation in the tRNA(Leu(UUR)) gene associated with maternally inherited cardiomyopathy. Hum Mutat 1994;3:37-43.
45. Ile mutation in fatal cardiomyopathy. Biochem Biophys Res Commun 1992;186:47-53.
46. Merante F, Myint T, Tein I, Benson L, Robinson BH. An additional mitochondrial tRNA(Ile) point mutation (A-to-G at nucleotide 4295) causing hypertrophic cardiomyopathy. Hum Mutat 1996;8:216-22.
47. Casali C, Santorelli FM, Gu DA, Bernucci P, DeBiase L, DiMauro S. A novel mtDNA point mutation in maternally inherited cardiomyopathy. Biochem Biophys Res Commun 1995;213:588-93.
48. Santorelli FM, Mak SC, Vazquez-Acevedo M, et al. A novel mitochondrial DNA point mutation associated with mitochondrial encephalocardiomyopathy. Biochem Biophys Res Commun 1995;216:835-40.
49. Santorelli FM, Mak SC, El-Schahawi M, et al. Maternally inherited cardiomyopathy and hearing loss associated with a novel mutation in the mitochondrial tRNA(Lys) gene (G8363A). Am J Hum Genet 1996;58:933-9.
50. Merante F, Tein I, Benson L, Robinson BH. Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA(glycine) gene. Am J Hum Genet 1994;55:437-46.
51. Moraes CT, Ciacci F, Silvestri G, et al. Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. Neuromusc Disord 1993;3:43-50.
52. Sweeney MG, Bundey S, Brockington M, Poulton KR, Winer JB, Harding AE. Mitochondrial myopathy associated with sudden death in young adults and a novel mutation in the mitochondrial DNA leucine transfer RNA(UUR) gene. Q J Med 1993;86:709-13.
53. Moraes CT, Ciacci F, Bonilla E, et al. Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot? J Clin Invest 1993;92:2906-15.
54. Chinnery PF, Johnson MA, Taylor RW, Durward WF, Turnbull DM. A novel mitochondrial tRNA isoleucine gene mutation causing chronic progressive external ophthalmoplegia. Neurology 1997;49:1166-8.
55. Silvestri G, Servidei S, Rana M, et al. A novel mitochondrial DNA point mutation in the tRNA(Ile) gene is associated with progressive external ophthalmoplegia. Biochem Biophys Res Commun 1996;220:623-7.
56. Ile gene:studies in a patient presenting with chronic progressive external ophthalmoplegia and multiple sclerosis. Biochem Biophys Res Commun 1998;243:47-51.
57. Seibel P, Lauber J, Klopstock T, Marsac C, Kadenbach B, Reichmann H. Chronic progressive external ophthalmoplegia is associated with a novel mutation in the mitochondrial tRNA(Asn) gene. Biochem Biophys Res Commun 1994;204:482-9.
58. Hattori Y, Goto YI, Sakuta R, Nonaka I, Mizuno Y, Horai S. Point mutations in mitochondrial tRNA genes:sequence analysis of chronic progressive external ophthalmoplegia (CPEO). J Neurol Sci 1994;125:50-5.
59. leu(UUR) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in muscle and suggests an approach to therapy. Hum Mol Genet 1996;5:1835-40.
60. Chinnery PF, Johnson MA, Taylor RW, Lightowlers RN, Turnbull DM. A novel mitochondrial tRNA phenylalanine mutation presenting with acute rhabdomyolysis. Ann Neurol 1997;41:408-10.
61. Goto Y, Tojo M, Tohyama J, Horai S, Nonaka I. A novel point mutation in the mitochondrial tRNA(Leu)(UUR) gene in a family with mitochondrial myopathy. Ann Neurol 1992;31:672-5.
62. Bindoff LA, Howell N, Poulton J, et al. Abnormal RNA processing associated with a novel tRNA mutation in mitochondrial DNA. A potential disease mechanism. J Biol Chem 1993;268:19559-64.
63. Met gene mutation in a patient with dystrophic muscle and excercise intolerance. Neurology 1998;50:1875-8.
64. Trp gene. Neuromusc Disord 1998;8:291-5.
65. Weber K, Wilson JN, Taylor L, et al. A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle. Am J Hum Genet 1997;60:373-80.
66. Moraes CT, Ciacci F, Bonilla E, Ionasescu V, Schon EA, DiMauro S. A mitochondrial tRNA anticodon swap associated with a muscle disease. Nat Genet 1993;4:284-8.
67. Hanna MG, Nelson I, Sweeney MG, et al. Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus:different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation. Am J Hum Genet 1995;56:1026-33.
68. Tiranti V, D'Agruma L, Pareyson D, et al. A novel mutation in the mitochondrial tRNA(Val) gene associated with a complex neurological presentation. Ann Neurol 1998;43:98-101.
69. Bidooki SK, Johnson MA, Chrzanowska-Lightowlers Z, Bindoff LA, Lightowlers RN. Intracellular mitochondrial triplasmy in a patient with two, heteroplasmic base changes. Am J Hum Genet 1997;60:1430-8.
70. Santorelli FM, Tanji K, Sano M, et al. Maternally inherited encephalopathy associated with a single-base insertion in the mitochondrial tRNATrp gene. Ann Neurol 1997;42:256-60.
71. Nelson I, Hanna MG, Alsanjari N, Scaravilli F, Morgan-Hughes JA, Harding AE. A new mitochondrial DNA mutation associated with progressive dementia and chorea:a clinical, pathological, and molecular genetic study. Ann. Neurol 1995;37:400-3.
72. Chinnery PF, Turnbull DM. Vomiting, anorexia and mitochondrial DNA disease. Lancet 1998;351:448.
73. Verma A, Piccoli DA, Bonilla E, Berry GT, DiMauro S, Moraes CT. A novel mitochondrial G8313A mutation associated with prominent initial gastrointestinal symptoms and progressive encephaloneuropathy. Pediatr Res 1997;42:448-54.
74. Chalmers RM, Lamont PJ, Nelson I, et al. A mitochondrial DNA tRNA(Val) point mutation associated with adult-onset Leigh syndrome. Neurology 1997;49:589-92.
75. Reid FM, Vernham GA, Jacobs HT A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness. Hum Mutat 1994;3:243-7.
76. Gattermann N, Retzlaff S, Wang YL, et al. A heteroplasmic point mutation of mitochondrial tRNALeu(CUN) in non-lymphoid haemopoietic cell lineages from a patient with acquired idiopathic sideroblastic anaemia. Br J Haematol 1996;93:845-55.
77. Prezant TR, Agapian JV, Bohlman MC, et al. Mitochondrial ribosomal RNA mutations associated with both antibiotic-induced and non-sydromic deafness. Nat Genet 1993;4:289-94.
78. Suomalainen A, Kaukonen J, Amati P, et al. An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet 1995;9:146-51.
79. Kaukonen JA, Amati P, Suomalainen A, et al. An autosomal locus predisposing to multiple deletions of mtDNA on chromosome 3p. Am J Hum Genet 1996;58:763-9.
80. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999;283:689-92.
81. Van den Heuvel L, Ruitenbeek W, Smeets R, et al. Demonstration of a new pathogenic mutation in human complex I deficiency:a 5-bp duplication in the nuclear gene encoding the 18kD (AQDQ) subunit. Am J Hum Genet 1998;62:262-8.
82. Loeffen J, Smeitink J, Treipels R, et al. The first nuclear-encoded complex I mutation in a patient with Leigh syndrome. Am J Hum Genet 1998;63:1598-608.
83. Taylor RW, Birch-Machin MA, Schaefer J, et al. Deficiency of complex II of the mitochondrial respiratory chain in late-onset optic atrophy and ataxia. Ann Neurol 1996;39:224-32.
84. Bougeron T, Rustin P, Birch-Machin M, et al. A mutation of nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency. Nat Genet 1995;11:144-9.
85. Zhu Z, Yao J, Johns T, et al. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 1998;20:337-43.
86. Tiranti V, Hoertnagel K, Carrozzo R, et al. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am J Hum Genet 1998;63:1609-21.
87. Tritschler HJ, Andreetta F, Moraes CT, et al. Mitochondrial myopathy of childhood associated with depletion of mitochondrial DNA. Neurology 1992;42:209-17.
88. Moraes CT, Shanske S, Tritschler HJ, et al. mtDNA depletion with variable tissue expression:a novel genetic abnormality in mitochondrial diseases. Am J Mum Genet 1991;48:492-501.
89. Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature 1981;290:457-65.
90. Chomyn A, Meola G, Bresolin N, Lai ST, Scarlato G, Attardi G. In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria. Mol Cell Biol 1991;11:2236-44.
91. Enriquez JA, Chomyn A, Attardi G. MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination. Nat Genet 1995;10:47-55.
92. Howell N. Human mitochondrial diseases:answering questions and questioning answers. Int Rev Cytol 1999;186:49-116.
93. Lightowlers RN, Chinnery PF, Turnbull DM, Howell N. Mammalian mitochondrial genetics:heredity, heteroplasmy and disease. Trends Genet 1997;13:450-5.
94. Schon EA, Bonilla E, DiMauro S. Mitochondrial DNA mutations and pathogenesis. J Bioenerg Biomembr 1997;29:131-49.
95. Servidei S. Mitochondrial encephalomyopathies:gene mutation. Neuromusc Disord 1999;9:XV-XXII.
96. Chinnery PF, Turnbull DM. Mitochondrial medicine. Q J Med 1997;90:657-66.
97. Chinnery PF, Turnbull DM. The clinical features, investigation and management of patients with mitochondrial DNA defects. J Neurol Neurosurg Psychiatry 1997;63:559-63.
98. Hirano M, Ricci E, Koenigsberger MR, et al. Melas: An original case and clinical criteria for diagnosis. Neuromusc Disord 1992;2:125-35.
99. Gerbitz K-D, van den Ouweland JMW, Maasen JA, Jaksch M. Mitochondrial diabetes:a review. Biochem Biophys Acta 1995;1271:253-60.
100. Vilarinho L, Santorelli FM, Rosas MJ, Tavares C, Melo-Pires M, DiMauro S. The mitochondrial A3243G mutation presenting as severe cardiomyopathy. J Med Genet 1997;34:607-9.
101. Nikoskelainen EK. Clinical picture of LHON. Clin Neurosci 1994;2:115-20.
102. Hanna MG, Vaughan JR, Silburn PA, et al. Two unusual clinical presentations of the mitochondrial DNA A3243G point mutation in adult neurological practice. J Neurol Neurosurg Psychiatry 1997;62:544-5.
103. Kimata KG, Gordan L, Ajax ET, Davis PH, Grabowski T. A case of late onset MELAS. Arch Neural 1998;55:722-5.
104. Howell N. Leber hereditary optic neuropathy:how do mitochondrial DNA mutations cause degeneration of the optic nerve? J Bioenerg Biomembr 1997;29:165-73.
105. Estivill X, Govea N, Barcelo A, et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides. Am J Hum Genet 1997;62:27-35.
106. Sue CM, Lipsett LJ, Crimmins DS, et al. Cochlear origin of hearing loss in MELAS syndrome. Ann Neurol 1998;43:350-9.
107. Mosewich RK, Donat JR, DiMauro S, et al. The syndrome of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes presenting without stroke. Arch Neurol 1993;50:275-8.
108. Klopstock T, May A, Seibel P, Papagiannuli E, Diener HC, Reichmann H. Mitochondrial DNA in migraine with aura. Neurology 1996;46:1735-8.
109. Chinnery P, Howell N, Lightowlers R, Turnbull D. Molecular pathology of MELAS and MERRF:the relationship between mutation load and clinical phenotype. Brain 1997;120:1713-21.
110. Wallace DC, Lott MT, Shoffner JM, Ballinger S. Mitochondrial DNA mutations in epilepsy and neurological disease. Epilepsia 1994;35(suppl 1):S43-50.
111. Jackson MJ, Schaefer JA, Johnson MA, Morris AAM, Turnbull DM, Bindoff LA. Presentation and clinical investigation of mitochondrial respiratory chain disease. Brain 1995;118:339-57.
112. Shoffner JM, Kaufman A, Koontz D, et al. Oxidative phosphorylation diseases and cerebellar ataxia. Clin Neurosci 1995;3:43-53.
113. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases and stroke. Heart Dis Srroke 1993;2:439-45.
114. Hanna MG, Bhatia KP. Movement disorders and mitochondrial dysfunction. Curr Opin Neurol 1997;10:351-6.
115. Hirano M, DiMauro S. Clinical features of mitochondrial myopathies and encephalomyopathies. In:Lane RJ, ed. Handbook of muscle disease. New York:Marcel Dekker, 1996:479-504.
116. Chu CC, Huang CC, Fang W, Chu NS, Pang CY, Wei YH. Peripheral neuropathy in mitochondrial encephalomyopathies. Eur Neurol 1997;37:110-15.
117. Hammans SR, Sweeney MG, Hanna MG, Brockington M, Morgan-Hughes JA, Harding AE. The mitochondrial DNA transfer RNALeu(UUR) A→G(3243) mutation. A clinical and genetic study. Brain 1995;118(pt 3):721-34.
118. Harding AE, Riordan-Eva P, Govan GG. Mitochondrial DNA diseases:genotype and phenotype in Leber's hereditary optic neuropathy. Muscle Nerve 1995;3:S82-4.
119. Zeviani M, Maiotti C, Antozzi C, Fratta GM, Rustin P, Prelle A. OXPHOS defects and mitochondrial DNA mutations in cardiomyopathy. Muscle Nerve 1995;3:S170-4.
120. Gerbitz KD, Gempel K, Brdiczka D. Mitochondria and diabetes. Genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes 1996;45:113-26.
121. Papadimitiou A, Hadjigeorgiou GM, Divari R, Papagalanis N, Comi G, Bresolin N. Influence of coenzyme Q10 on total serum calcium concentration in two patients with Kearns-Sayre syndrome and hypoparathyroidism. Neuromusc Disord 1996;6:49-53.
122. Tulinius MH, Oldfors A, Holme E, et al. Atypical presentation of multisystem disorders in two girls with mitochondrial DNA deletions. Eur J Pediatr 1995;154:35-42.
123. Bhattacharyya A, Tymms DJ. Mitochondrial DNA defects and endocrine dysfunction. Q J Med 1998;91:375-6.
124. Chen CM, Huang CC. Gonadal dysfunction in mitochondrial encephalomyopathies. Eur Neurol 1995;35:281-6.
125. Folgero T, Bertheussen K, Lindal S, Torbergsen T, Oian P. Mitochondrial disease and reduced sperm motility. Hum Reprod 1993;8:1863-8.
126. Boles RG, Chun N, Senadheera D, Wond LJC. Cyclical vomiting syndrome and mitochondrial DNA mutations. Lancet 1997;350:1299-300.
127. Hirano M, Silvestri G, Blake DM, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE):clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994;44:721-7.
128. Heil JAP, Verrips A, Keyser A, et al. Ileus in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes. Neth J Med (in press).
129. Shoffner JM, Voljavec AS, Dixon J, Kaufman A, Wallace DC, Mitch WE. Renal amino acid transport in adults with oxidative phosphorylation diseases. Kidney Int 1995;47:1101-7.
130. Eviatar L, Shanske S, Gauthier B, et al. Kearns-Sayre syndrome presenting as renal tubular acidosis. Neurology 1990;40:1761-3.
131. Szabolcs MJ, Seigle R, Shanske S, Bonilla E, DiMauro S. Mitochondrial DNA deletion:a cause of chronic tubulointerstitial nephropathy. Kidney Int 1994;45:1388-96.
132. Niaudet P, Heidet L, Munnich A, et al. Deletion of the mitochondrial DNA in a case of de Toni-Debre-Fanconi syndrome and Pearson syndrome. Pediatr Nephrol 1994;8:164-8.
133. Morris AA, Taylor RW, Birch-Machin MA, et al. Neonatal Fanconi syndrome due to deficiency of complex III of the respiratory chain. Pediatr Nephrol 1995;9:407-11.
134. Goto Y, Itami N, Kajii N, Tochimaru H, Endo M, Horai S. Renal tubular involvement mimicking Banter syndrome in a patient with Kearns-Sayre syndrome. J Pediatr 1990;116:904-10.
135. Rotig A, Cormier V, Blanche S, Bonnefont JP, Ledeist F. Pearson's marrow pancreas syndrome. A multisystem mitochondrial disorder of infancy. J Clin Invest 1990;86:1601-8.
136. Leu(UUR) mutation. J Med Genet 1998;35:255-7.
137. Munnich A, Rotig A, Chretien D, et al. Clinical presentation of mitochondrial disorders in childhood. J Inherit Metab Dis 1996;19:521-7.
138. Suomalainen A, Kaukonen J, Amati P, et al. An autosomal locus predisposing to deletions of mitochondrial DNA. Nat Genet 1995;9:146-51.
139. Onishi H, Kawanishi C, Iwasawa T, et al. Depressive disorder due to mitochondrial transfer RNALeu(UUR) mutation. Biol Psychiatr 1997;41:1137-9.
140. Thomeer EC, Verhoeven WMA, Van de Vlasakker CJW, Klompenhouwer JL. Psychiatric symptoms in MELAS:a case report. J Neurol Neurosurg Psychiatry 1998;64:692-3.
141. Larsson NG, Tulinius MH, Holme E, Oldfors A. Pathogenetic aspects of the A8344G mutation of mitochondrial DNA associated with MERRF syndrome and multiple symmetric lipomas. Muscle Nerve 1995;3:S102-6.
142. Howell N, Kubacka I, Smith R, Frerman F, Parks JK, Parker WD Jr. Association of the mitochondrial 8344 MERRF mutation with maternally inherited spinocerebellar degeneration and Leigh disease. Neurology 1996;46:219-22.
143. Shoffner JM, Brown MD, Stugard C, et al. Leber's hereditary optic neuropathy plus dystonia is caused by a mitochondrial DNA point mutation. Ann Neurol 1995;38:163-9.
144. Bruyn GW, Bots GT, Went LN, Klinkhamer PJ. Hereditary spastic dystonia with Leber's hereditary optic neuropathy:neuropathological findings. J Neural Sci 1992;113:55-61.
145. Mansergh FC, Millington-Ward S, Kennan A, et al. Retinitis pigmentosa and progressive sensorineural hearing loss caused by a C12258A mutation in the mitochondrial MTTS2 gene. Am J Hum Genet 1999;64:971-85.
146. Henderson GV, Kittner SJ, Johns DR. An incidence study of stroke secondary to MELAS in the young. Neurology 1997;48:A403.
147. Majamma K, Turkka J, Karppa M, Winqvist S, Hassinen IE. The common MELAS mutation A3243G in mitochondrial DNA among patients with an occipital infarct. Neurology 1997;49:1331-4.
148. glycine gene. Am J Hum Genet 1994;55:437-46.
149. Matsutani H, Mizusawa Y, Shimoda M, et al. Partial deficiency of cytochrome c oxidase with isolated proximal renal tubular acidosis and hypercalciuria. Child Nephrol Urol 1992;12:221-4.
150. Damian MS, Seibel P, Reichmann H, et al. Clinical spectrum of the MELAS mutation in a large pedigree. Acta Neurol Scand 1995;92:409-15.
151. Zupanc ML, Moraes CT, Shanske S, Langman CB, Ciafaloni E, DiMauro S. Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol 1991;29:680-3.
152. North K, Korson MS, Krawiecki N, Shoffner JM, Holm IA. Oxidative phosphorylation defect associated with primary adrenal insufficiency. J Pediatr 1996;128(pt 1):688-92.
153. Bruno C, Minetti C, Tang Y, et al. Primary adrenal insufficiency in a child with a mitochondrial DNA deletion. J Inherit Metab Dis 1998;21:155-161.
154. Maassen J, Kadowaki T. Maternally inherited diabetes and deafness:a new diabetes subtype. Diabetologia 1996;39:375-82.
155. Gardner JC, Goliath R, Viljoen D, et al. Familial streptomycin ototoxicity in a South African family:a mitochondrial disorder. J Med Genet 1997;34:904-6.
156. Brown GK, Otero LJ, LeGris M, Brown RM. Pyruvate dehydrogenase deficiency. J Med Genet 1994;31:875-9.
157. DiMauro S, DeVivo DC. Genetic heterogeneity in Leigh syndrome. Ann Neurol 1996;40:5-7.
158. Santorelli FM, Shanske S, Macaya A, DeVivo DC, DiMauro S. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol 1993;34:827-34.
159. Van der Knaap MS, Jakobs C, Valk J. Magnetic resonance imaging in lactic acidosis. J Inherit Metab Dis 1996;19:535-47.
160. Barkovich AJ, Good WV, Koch TK, Berg BO. Mitochondrial disorders:analysis of their clinical and imaging characteristics. Am J Neuroradiol 1993;14:1119-37.
161. Wray SH, Provenzale JM, Johns DR, Thulborn KR. MR of the brain in mitochondrial rnyopathy. Am J Neuroradiol 1995;16:1167-73.
162. Matthews PM, Tampieri D, Berkovic SF, et al. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology 1991;41:1043-6.
163. Larsson NG, Clayton DA. Molecular genetic aspects of human mitochondrial disorders. Annu Rev Genet 1995;29:151-78.
164. Hammans SR, Sweeney MG, Brockington M, et al. The mitochondrial DNA transfer RNA(Lys)A→G(8344) mutation and the syndrome of myoclonic epilepsy with ragged red fibres (MERRF). Relationship of clinical phenotype to proportion of mutant mitochondrial DNA. Brain 1993;116(pt 3):617-32.
165. Howell N, Bindoff LA, McCullough DA, et al. Leber hereditary optic neuropathy:identification of the same mitochondrial ND1 mutation in six pedigrees. Am J Hum Genet 1991;49:939-50.
166. Howell N. Primary LHON mutations:trying to separate "fruyt" from "chaf" Clin Neurosci 1994;2:130-7.
167. Chinnery PF, Reading PJ, Walls TJ, Turnbull DM. Recurrent strokes in a 34 year old man. Lancet 1997;350:560.
168. Morgan-Hughes JA. Mitochondrial diseases. In:Engel AG, Franzini-Armstrong C, eds. Myology. New York:McGraw-Hill, 1994:1610-60.
169. Johnson MA, Barron MJ. Muscle biopsy analysis. In:Lane RJM, ed. Handbook of muscle disease. New York:Marcel Dekker, 1996.
170. Kawakami Y, Sakuta R, Hashimoto K, et al. Mitochondrial myopathy with progressive decrease in mitochondrial tRNA(Leu) (UUR) mutant genomes. Ann Neurol 1994;35:370-3.
171. Howell N. Leber hereditary optic neuropathy:mitochondrial mutations and degeneration of the optic nerve. Vision Res 1997;37:3495-507.
172. Chinnery PF, Zwijnenburg PJG, Howell N, et al. Non-random tissue distribution of mutant mitochondrial DNA. Am J Med Genet (in press).
173. Zeviani M, Gellera C, Pannacci M, et al. Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies. Ann Neurol 1990;28:94-7.
174. Larsson NG, Eiken HG, Boman H, Holme E, Oldfors A, Tulinius MH. Lack of transmission of deleted mtDNA from a woman with Kearns-Sayre syndrome to her child. Am J Hum Genet 1992;50:360-3.
175. Rotig A, Bessis JL, Romero N, et al. Maternally inherited duplication of the mitochondrial genome in a syndrome of proximal tubulopathy, diabetes mellitus, and cerebellar ataxia. Am J Hum Genet 1992;50:364-70.
176. Dunbar DR, Moonie PA, Swingler RJ, Davidson D, Roberts R, Holt IJ. Maternally transmitted partial direct tandem duplication of mitochondrial DNA associated with diabetes mellitus. Hum Mol Genet 1993;2:1619-24.
177. Ballinger SW, Shoffner JM, Gebhart S, Koontz DA, Wallace DC. Mitochondrial diabetes revisited. Nat Genet 1994;7:458-9.
178. Poulton J, Holt IJ. Mitochondrial DNA:does more lead to less? Nat Genet 1994;8:313-15.
179. Manfredi G, Vu T, Bonilla E, et al. Association of myopathy with large-scale mitochondrial DNA duplications and deletions:which is pathogenic? Ann Neurol 1997;42:180-8.
180. Poulton J, Deadman ME, Bindoff L, Morten K, Land J, Brown G. Families of mtDNA re-arrangements can be detected in patients with mtDNA deletions:duplications may be a transient intermediate form. Hum Mol Genet 1993;2:23-30.
181. Harding AE, Sweeney MG, Govan GG, Riordan-Eva P. Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation. Am J Hum Genet 1995;57:77-86.
182. Macmillan C, Kirkham T, Fu K, et al. Pedigree analysis of Leber's hereditary optic neuropathy families with the T14484C mtDNA mutation. Neurology 1997;49:A245.
183. Poulton J, Macaulay V, Marchington DR. Mitochondrial genetics '98:ss the bottleneck cracked? Am J Hum Genet 1998;62:752-7.
184. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. Genetic counseling and prenatal diagnosis of mtDNA disease. Am J Hum Genet 1998;63:1908-10.
185. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. MELAS and MERRF:the relationship between maternal mutation load and the frequency of clinically affected offspring. Brain 1998;121:1889-994.
186. T>G disease. Am J Hum Genet 1992;50:629-33.
187. Matthews PM, Hopkin J, Brown RM, Stephenson JB, Hilton-Jones D, Brown GK. Comparison of the relative levels of the 3243 (A→G) mtDNA mutation in heteroplasmic adult and fetal tissues. J Med Genet 1994;31:41-4.
188. Taylor RW, Chinnery PF, Clark KM, Lightowlers RN, Turnbull DM. Treatment of mitochondrial disease. J Bioenerg Biomembr 1997;29:195-205.
189. Gold R, Seibel P, Reinelt G, et al. Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies:results of a 6-month therapy study with coenzyme Q. Eur Neurol 1996;36:191-6.
190. Eleff S, Kennaway NG, Buist NR, et al. 31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in
191. 31P NMR study. Neurology 1989;39:339-43.
192. Bresolin N, Doriguzzi C, Ponzetto C, et al. Ubidecarenone in the treatment of mitochondrial myopathies:a multicenter double-blind trial. J Neurol Sci 1990;100:70-8.
193. Taivassalo T, De Stefane N, Matthews PM, et al. Aerobic training benefits patients with mitochondrial myopathies more than other chronic myopathies. Neurology 1997;48:A214.
194. Taylor RW, Chinnery PF, Turnbull DM, Lightowlers RN, Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nat Genet 1997;15:212-15.
195. Shoubridge EA, Johns T, Karpati G. Complete restoration of a wild-type mtDNA genotype in regenerating muscle fibres in a patient with a tRNA point mutation and mitochondrial encephalomyopathy. Hum Mol Genet 1997;6:2239-42.
196. Clark K, Bindoff LA, Lightowlers RN, et al. Correction of a mitochondrial DNA defect in human skeletal muscle. Nat Genet 1997;16:222-4.